Golden logoGolden logo
Advanced Search
Roche Holding

Roche Holding

Roche is a multi-national healthcare company that develops pharmaceuticals and diagnostics that improve people's lives

Roche is a multi-national healthcare company that develops pharmaceuticals and diagnostics that improve people's lives. The company was founded in 1986 by Fritz Hoffman-La Roche, in Basel, Base-Stadt, Switzerland.

The company has the mission to provide urgent delivery of medical solutions to improve patients lives. The company has created several medical products such as Alecensa, Avastin, Bactrim, Dilatrend, Fuzeon, Hemlibra, Lucentusm Beupogen, Pegasys, Viracept, Xolair, and Actemra.

COVID-19 treatment and diagnostics

Since the outbreak of COVID-19, China approved the use of Roche's Actemra for patients with severe cases of coronavirus. The drug has the ability to prevent overreactions in the immune system, which is the leading cause of organ failure deaths in some coronavirus patients. The drug is part of a clinical trial that would be conducted until May, 2020.

Actemra is used as an anti-inflammation drug, and works to treat coronavirus patients with severe lung damage and high IL-6 levels. The drug was originally administered as a treatment of rheumatoid arthritis. The drug will be administered in the US, Italy, Switzerland, France, and Germany.

For COVID-19 diagnostics the FDA granted emergency use authorization (EUA) for a nucleic acid detection test (RT-PCR) that runs on Roche’s cobas 6800/8800 automated systems which can test 4,128 (8800 system) or 1,400 patients (6800 system) per day and provide results in 4 hours. The test is also available in Europe in countries that accept CE marking. The cobas SARS-CoV-2 test is the third test granted emergency approval by the FDA and the first commercially available one. The cobas systems were launched in 2014 and are widely available globally. As of March, 2020 there are 695 of the 6800 instruments and 132 of the 8800 instruments installed.

Roche Diagnostics is a Swiss sales organization of the Diagnostics Division of the F. Hoffmann-La Roche Group that is based in Rotkreuz, Canton zug. Roche Diagnostics develops and integrates diagnostic solutions that solves the challenges of today and anticipate the needs of tomorrow.

The company offers the industry’s most comprehensive In vitro diagnostics solutions, covering molecular diagnostics, clinical chemistry and immunoassays, tissue diagnostics, point of care testing, patient self-testing, next-generation sequencing, and laboratory automation and IT, and decision support solutions in more than 100 countries.

The company recognized its leadership position in vitro diagnostics in the world and Swiss markets as an obligation to its partners. Roche Diagnostics has motivated employees that are committed to its healthcare partners.

The company supports the success of research centers, hospitals, and private laboratories as well as medical practices with achievements and thus contributes significantly to patients' well-being. Roche Diagnostics serves customers from across the healthcare sector, from commercial laboratories, research facilities and hospitals to doctors and patients.


September 12, 2011
Roche Holding raises a $15,000,000 series A round from HealthCare Ventures.

Funding Rounds




Further Resources


Actemra; coronavirus complications to be treated under Chinese approval


March 5, 2020

Coronavirus outbreak: Top coronavirus drugs and vaccines in development


March 11, 2020

Roche - A global history.


February 22, 2022


Global Market Insights Inc.
May 26, 2021
/PRNewswire/ -- According to the latest report, "PCR and NGS based Diagnostic Testing Market by Product (Consumables, Equipment, Labware), End-Use (Hospitals...
June 1, 2020
Health news, Medibulletin
As ICMR asks states to conduct serological surveys to find prevalence of COVID19, Roche says want to explore partnerships in India
Guy Faulconbridge
May 14, 2020
Britain is in talks with Swiss drugmaker Roche Holding AG to buy an accurate COVID-19 antibody test, following the lead of the European Union and United States, which had already given preliminary approval to the tests.
John Miller
May 11, 2020
Fritz Gerber, the long-time head of Roche Holding who helped transform the Swiss company from an image-tarnished vitamins, drugs and chemicals conglomerate into a biotechnology and diagnostics giant, has died at the age of 91.
Sohini Das
May 1, 2020
Players like Abbott, Roche, Trivitron, Eris get approvals to import chemiluminescent kits, ELISA kits too get nod


Golden logo
By using this site, you agree to our Terms of Service.